EUVIMEDEUVIMED entdecken
Crossref

Digitalizing the TIM-1 Model using Computational Approaches–Part One: TIM-1 Data Explorer

Inese Sarcevica, Bart Hens iD, Irena Tomaszewska, Mark McAllister

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Inese Sarcevica und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Product Design, Pfizer, Discovery Park, Ramsgate Road, Sandwich CT13 9ND, U.K. Hauptthemen laut MEDLINE: Gastrointestinal Tract, Stomach. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates the dynamic environment of the human gastrointestinal tract, including pH, transfer times, secretion of bile, enzymes, and electrolytes. In the pharmaceutical industry, the TIM-1 system is used to support drug product design and provide a biopredictive assessment of drug product performance. Typically, the bioaccessibility data sets generated by TIM-1 experiments are used to qualitatively compare formulation performance, and the use of bioaccessibility data as inputs for physiologically based pharmacokinetic (PBPK) modeling for quantitative predictions is limited. To expand the utility of the TIM-1 model beyond standard bioaccessibility measurements (which define the fraction available for absorption), we have developed a computational tool, TIM-1 Data Explorer, to describe the fluid and mass balance within the TIM-1 system. The use of this tool allows a detailed inspection and in-depth interpretation of the experimental data. In addition to mass balance calculation, this model also can be used to describe the critical processes a drug substance would undergo during a TIM-1 experiment, such as dissolution, precipitation on transfer from the stomach to duodenum, and redissolution. The TIM-1 Data Explorer was validated in two case studies. In the first case study with paracetamol, we have shown the ability of the simulator to adequately describe mass transfer events within the TIM-1 system, and in the second study with a weakly basic in-house compound, PF-07059013, the TIM-1 Data Explorer was successfully used to describe dissolution and precipitation processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal TractStomachHumansComputer SimulationDuodenumIntestinal AbsorptionModels, Biological

Stichwörter der Autor:innen

PBPK modelingdigital modelin silico modelingin vitro dissolutionoral biopharmaceutics

Autor:innen und Institutionen

  • Drug Product Design, Pfizer, Discovery Park, Ramsgate Road, Sandwich CT13 9ND, U.K.

ORCID-Profile: Bart Hens

Zitieren

APA

Sarcevica, I., Hens, B., Tomaszewska, I., & McAllister, M. (2023). Digitalizing the TIM-1 Model using Computational Approaches–Part One: TIM-1 Data Explorer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00422

Vancouver

Sarcevica I, Hens B, Tomaszewska I, McAllister M. Digitalizing the TIM-1 Model using Computational Approaches–Part One: TIM-1 Data Explorer. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00422

BibTeX
@article{Sarcevica2023,
  author = {Sarcevica, Inese and Hens, Bart and Tomaszewska, Irena and McAllister, Mark},
  title = {Digitalizing the TIM-1 Model using Computational Approaches–Part One: TIM-1 Data Explorer},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00422}
}
Kostenlos starten →